Watch Demo

Japan Antidiabetics Industry Outlook 2024 - 2028

See how Japan Antidiabetics performed compared to key markets.

Key Market Indicators

**Japanese Insulin Import Decline Forecasted** Japan's insulin import is projected to decrease from approximately $344 million in 2023 to around $312 million by 2028. This represents a year-on-year compound annual growth rate (CAGR) decline of 1.7%. Historical data since 1993 indicates a consistent annual decrease in demand, averaging 2.4% per year. **Insulin Export on the Rise Despite Historical Decline** Conversely, Japan's insulin exports are expected to increase from about $155,000 in 2023 to nearly $184,000 by 2028. This growth translates to an average annual growth rate of 2.6%, despite a historical yearly decline of 21.4% since 2000. **Global Rankings and Competitors** In 2023, Japan ranked 32nd in insulin exports, with Morocco slightly ahead at the same value of $155,000. Leading the global rankings were France, Italy, and China, occupying the second, third, and fourth positions respectively.

Marketing Banner

Japan Antidiabetics Market Data and Forecasts

How much will Japan Antidiabetics Market grow to 2028?

Forecast: Insulin in Dosage Market Size Value in Japan
Forecast: Import of Insulin in Dosage Forms to Japan
Forecast: Import of Insulin to Japan
Forecast: Import of Insulin in Dosage Forms to Japan
More in Antidiabetics Industry for 2028